Zheng Quan Ri Bao·2025-08-19 13:33Core Insights - The announcements highlight various companies' financial performances and strategic decisions, including profit growth, dividend proposals, and investment activities. Financial Performance - Jibite reported a 24.5% year-on-year increase in net profit for the first half of 2025, with revenue growth of 28.49% [4] - Keli Yuan achieved a net profit of 51.22 million yuan, marking a 187.23% increase year-on-year [3] - Yinlong Co. saw a 70.98% increase in net profit, reaching 17.2 million yuan [6] - Xianda Co. experienced a remarkable 2561.58% increase in net profit, totaling 13.6 million yuan [7] - Jinli Yongci reported a 154.81% increase in net profit, amounting to 305 million yuan [11] - Beisimei's net profit grew by 109.7% to 34.71 million yuan [12] - Zhongnan Culture's net profit surged by 524.45% to 60.99 million yuan [13] - Blue Ocean Huaten reported a net profit increase of 159.83%, reaching 41.12 million yuan [15] Dividend Proposals - Jibite plans to distribute a cash dividend of 66 yuan per 10 shares [4] - Huadong Pharmaceutical proposes a cash dividend of 3.5 yuan per 10 shares [8] - Jinli Yongci intends to distribute a cash dividend of 1.8 yuan per 10 shares [11] - Blue Ocean Huaten also plans to distribute a cash dividend of 1.8 yuan per 10 shares [15] Strategic Decisions - Anfu Technology intends to acquire a 31% stake in Anfu Energy for 1.152 billion yuan and raise matching funds [5] - Wanfu Biological decided to terminate a joint investment project with an affiliated company [10] - Dazhi clarified that it has not engaged in "cross-border payment" or related businesses, despite market speculation [2]